She will complete a comparative study between between CO2 emissions in the European and North American markets at the Center for Climate Change of Columbia University

Isabel Rodríguez Martínez, Professor of Trade Law at the Faculty of Law, Business and Political Science of CEU Cardenal Herrera University, will do a research stay during July and August at the prestigious and world-renowned Center for Climate Change Law, a center specialized in climate change affiliated with Columbia Law School (New York). This center seeks to develop the legal structures and techniques needed to understand and respond to climate variability and to train law professionals within a multidisciplinary approach to sustainable development.

The goal of her stay, which will be supervised by Professor Alejandro M. Garro, Adjunct  Professor of Law at Columbia University School of Law, will be to understand the functioning of North American markets regarding CO2 emissions and to complete a comparative paper with the EU market. Professor Isabel Rodríguez is the head of the CEU-UCH research group “Legal protection of the investor in new unregulated GEI-emission markets”, unique research group in its genre.

Based on this topic, Professor Isabel Rodríguez presented last February the book “Regime and Transmission of Global Greenhouse Gas Emissions and Carbon Credits”. In this book, recently awarded Honorable Mention at the Ángel Herrera Awards to the Best Research Works on Social Sciences, CEU-UCH researcher has set the legal foundations of greenhouse gas emissions (GEI), economic instruments to fight against climate change.

This paper has caught the attention of the CNMV – Spanish Securities & Exchange Commission – and has been supported by SENDECO2, the Electronic Negotiating System for GreenHouse Emissions.

Previous articleBabson College is the first of the top ranked American Business Schools for Business and Entrepreneurship, according to Princeton Review
Next articleCEU-UCH receives 225 000 euros from Javea Cancer Care intended for clinical research in personalized treatments against cancer by the English Cathedra of Modern Oncology Research